Actively Recruiting
Bright Light Therapy on Sleep Health in Lung Cancer Patients
Led by Henry Ford Health System · Updated on 2025-07-14
20
Participants Needed
1
Research Sites
37 weeks
Total Duration
On this page
Sponsors
H
Henry Ford Health System
Lead Sponsor
M
Michigan State University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this randomized intervention trial is to determine the effect of bright light therapy on sleep disturbance, as well as to investigate the impacts of bright light therapy on biological age measured by clinical biomarkers. The main questions it aims to answer are: * Does bright light therapy improve sleep patterns (i.e., sleep onset latency, sleep disturbance, and sleep efficiency) in lung cancer patients? * Can bright light therapy slow the rate of aging measured by biological age in lung cancer patients? Researchers will compare bright light therapy group to control group to see if bright light works to reduce sleep disturbance and decelerate biological aging. Participants will: * Receive bright light exposure or usual light exposure every day for 4 weeks * Get blood draw at the baseline and at 4 weeks for clinical biomarkers tests * Complete self-reported sleep, fatigue and stress surveys at the baseline and at 4 weeks * Keep a daily sleep log
CONDITIONS
Official Title
Bright Light Therapy on Sleep Health in Lung Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age or older
- Diagnosed with stage Ib to IIIb primary lung cancer
- At least 2 months after completion of primary therapy; may be on maintenance or immunotherapy
- ECOG performance status 0 or 1
- Experience problematic sleep with Insomnia Severity Index score of 8 or higher
- Able to understand, speak, and read English
- Sighted and mentally competent to give consent
You will not qualify if you...
- Pregnant women
- Metastatic cancer
- On oxygen therapy
- Current diagnosis of seasonal affective disorder or substance abuse
- Engage in shift work or have traveled across more than 3 time zones within 2 weeks before the study
- Currently treated for sleep apnea, restless legs syndrome, or narcolepsy
- Taking prescribed sedative hypnotics or antipsychotics
- Eye conditions like glaucoma or retinal disease, or problems triggered by bright light such as migraine
- Taking photosensitizing medications (e.g., some porphyrin drugs, antipsychotics, antiarrhythmic agents)
- Insomnia Severity Index score less than 8
- Cognitive impairment indicated by mini-cog test score less than 3
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Henry Ford Health System
Detroit, Michigan, United States, 48202
Actively Recruiting
Research Team
M
Menghua Tao, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here